Argent BioPharma Jumps 86% After Bold AusCann Acquisition
Argent BioPharma Expands with AusCann Deal On August 19, Argent BioPharma (ASX: RGT) announced it was buying AusCann’s assets, which…
Magnetite Mines Surges 181%: Is Ironback Hill the Next Rare Earth Breakthrough?
Rarely does a stock surge 181% overnight on the back of old drill samples. That’s exactly what happened when Magnetite…
Nvidia (NSDQ: NVDA) Earnings: Can the AI Giant Keep Beating Wall Street?
Nvidia Q2 Preview: Can the AI Leader Keep Beating Expectations? For the past two years, Nvidia (NSDQ: NVDA) has delivered…
CSL FY25 Analysis 14% Profit Growth Despite Slower Revenue Growth
CSL’s Growth Slows, Profits Surge: What Investors Need to Know For decades, CSL Limited (ASX: CSL) has been regarded as…
This Phase 2 ASX Biotech stock is only at cash backing, but has enormous upside!
Phase 2 ASX Biotech stocks tend to be capitalised at $40-110m, but Percheron (ASX:PER) is only at cash backing. In…
Kaili Resources (ASX:KLR): From $0.04 to $1.08 in a single day…what caused the exponential rise?
Kaili Resources (ASX:KLR) made one of the biggest one-day gains in recent memory yesterday (August 18), closing at $1.08 after…
Eli Lilly (NYSE:LLY): This US$700bn company is set to beat Novo Nordisk & Ozempic even with this month’s hiccup
For investors who missed the run in Novo Nordisk shares, Eli Lilly (NYSE:LLY) appeared to be the next best thing.…
Share buybacks: Are they a good sign or a waste of money?
Share buybacks are a controversial topic amongst investors. Some say it is a waste of money, others will welcome it…
Speed and Precision: Trading Approaches for Volatile Forex Markets
Some days in the forex market feel calm, with prices drifting slowly from one level to the next. Other days,…
The 50/30/20 Rule for Modern Digital Leisure Spending
The 50/30/20 rule — 50% for needs, 30% for wants, 20% for savings — has long been a trusted personal…
ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?
What does the next few years hold for ASX Health Care Stocks Under Trump? There’s no doubt that the health…
Underlying v Statutory results? There’s a big difference between the 2 – here’s how to tell
When companies report results every reporting season, you’ll hear underlying and statutory results. What is the difference between the two…
Merck & Co (NYSE:MRK): Its a top 5 healthcare company, but needs to figure out its post-Keytruda future
Merck & Co (NYSE:MRK) is one of the world’s most prominent healthcare companies. The healthcare industry is perceived by many…
Here are 6 ASX stocks at 12 month highs, and whether it is time to buy
Here are 6 ASX stocks at 12 month highs! Liontown Resources (ASX:LTR) Liontown’s Kathleen Valley has been producing since…
Why Dateline Resources (ASX: DTR) Is on Investor Watchlists After a 3,000% Rally
Dateline Resources (ASX: DTR) Holds 1M+ Oz Gold and Possible REE Upside It is not often you find a project…